We found that low-level WT1 expression is associated with a higher incidence of multiple concurrent mutations per patient, particularly those linked to CHIP and marrow dysplasia, as defined in the recent ICC classification [24]. Here, WT1 is linked to intrahepatic cholangiocarcinoma.